Journal Article

Altered brain expression and cerebrospinal fluid levels of TIMP4 in cerebral amyloid angiopathy

Stellingwerf, Arno, Jäkel, Lieke, Verbeek, Marcel M., Hernández Utrilla, Carla, Kuiperij, H. Bea, De Kort, Anna M., Vervuurt, Marc, Klijn, Catharina J. M., Kersten, Iris, Schreuder, Floris H. B. M., Vermeiren, Yannick, Küsters, Benno

2024

Overview

Cerebral amyloid angiopathy (CAA) is a highly prevalent and progressive pathology, involving amyloid-β (Aβ) deposition in the cerebral blood vessel walls. CAA is associated with an increased risk for intracerebral hemorrhages (ICH). Insight into the molecular mechanisms associated with CAA pathology is urgently needed, to develop additional diagnostic tools to allow for reliable and early diagnosis of CAA and to obtain novel leads for the development of targeted therapies. Tissue inhibitor of matrix metalloproteinases 4 (TIMP4) is associated with cardiovascular functioning and disease and has been linked to vascular dementia. Using immunohistochemistry, we studied occipital brain tissue samples of 57 patients with CAA (39 without ICH and 18 with ICH) and 42 controls, and semi-quantitatively assessed expression levels of TIMP4. Patients with CAA had increased vascular expression of TIMP4 compared to controls ( p  < 0.001), and in these patients, TIMP4 expression correlated with CAA severity (τ b  = 0.38; p  = 0.001). Moreover, TIMP4 expression was higher in CAA-ICH compared to CAA-non-ICH cases ( p  = 0.024). In a prospective cross-sectional study of 38 patients with CAA and 37 age- and sex-matched controls, we measured TIMP4 levels in cerebrospinal fluid (CSF) and serum using ELISA. Mean CSF levels of TIMP4 were decreased in patients with CAA compared to controls (3.36 ± 0.20 vs. 3.96 ± 0.22 ng/ml, p  = 0.033), whereas median serum levels were increased in patients with CAA (4.51 ng/ml [IQR 3.75–5.29] vs 3.60 ng/ml [IQR 3.11–4.85], p -9.013). Moreover, mean CSF TIMP4 levels were lower in CAA patients who had experienced a symptomatic hemorrhage compared to CAA patients who did not (2.13 ± 0.24 vs. 3.57 ± 0.24 ng/ml, p  = 0.007). CSF TIMP4 levels were associated with CSF levels of Aβ40 (spearman r (r s ) = 0.321, p  = 0.009). In summary, we show that TIMP4 is highly associated with CAA and CAA-related ICH, which is reflected by higher levels in the cerebral vasculature and lower levels in CSF. With these findings we provide novel insights into the pathophysiology of CAA, and more specifically in CAA-associated ICH.

• Publisher: BioMed Central,BioMed Central Ltd,BMC
• Subject: Aged / Aged, 80 and over / Amyloid beta-Peptides - cerebrospinal fluid / Amyloid beta-Peptides - metabolism / Biomarker / Biomedical and Life Sciences / Biomedicine / Brain - metabolism / Brain - pathology / Cerebral amyloid angiopathy / Cerebral Amyloid Angiopathy - cerebrospinal fluid / Cerebral Amyloid Angiopathy - pathology / Cerebral Hemorrhage - cerebrospinal fluid / Cerebral Hemorrhage - metabolism / Female / Humans / Immunohistochemistry / Intracerebral hemorrhage / Male / Medical research / Medicine, Experimental / Middle Aged / Neurology / Neurosciences / Pathology / Tissue Inhibitor of Metalloproteinase-4 / Tissue Inhibitor of Metalloproteinases - cerebrospinal fluid / Tissue Inhibitor of Metalloproteinases - metabolism / Tissue inhibitor of metalloproteinases 4